https://www.selleckchem.com/products/NXY-059.html
A novel, multi-dimensional protocol named GENIE has been in use for intensive insulin therapy (IIT, target glucose less then 140 mg/dL) in the surgical intensive care unit (SICU) after open heart surgery (OHS) at VA Pittsburgh since 2005. Despite concerns over increased mortality from IIT after the publication of the NICE-SUGAR Trial, it remains in use, with ongoing monitoring under the MAGIC GENIE Project showing that GENIE performance over 12 years (2005-2016) aligns with the current consensus that IIT with target blood glucose (BG) l
Like
Comment
Share
